Hennion & Walsh Asset Management »

Rapt Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $96k 48k 2.01
2024-06-30 $148k 49k 3.05
2024-03-31 $401k 45k 8.98
2023-12-31 $1.1M 44k 24.85
2023-09-30 $674k 41k 16.62
2023-06-30 $400k 21k 18.69

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Intl Qulty Div (IQDG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Investment Grade (IGEB)
Proshares Tr S&p 500 High Inc (ISPY)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
Global X Fds Us Pfd Etf (PFFD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Insured Tax-Free Adv Munici (NEA)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Apple (AAPL)

View all positions for Hennion & Walsh Asset Management

Top funds holding Rapt Therapeutics

Vanguard Group
Column Group
BlackRock
BlackRock
Kingdon Capital Management
Morgan Stanley
D. E. Shaw & Co
Acadian Asset Management
Federated Investors
Two Sigma Advisers
Geode Capital Management
State Street Corporation
Euclidean Capital
Two Sigma Investments
Alphabet

View all funds holding Rapt Therapeutics